Determining Value

We found for

Insight
November 2023

OHE’s AMR consultation response

Insight
October 2022

The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot

The Value of Vaccines in Maintaining Health System Capacity in England

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?

The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

Ten Years of the NIHR: Achievements and Challenges for the Next Decade

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies?

Real Option Value and Path Dependence in Oncology Innovation

Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?

Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

The Publicly Funded Vaccines Market in the UK

The Publicly Funded Vaccines Market in Australia

Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?

The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?

Latest Research & Publications

All Publications

We found for

Filter results by

OHE’s AMR consultation response

The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot

The Value of Vaccines in Maintaining Health System Capacity in England

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?

The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

Ten Years of the NIHR: Achievements and Challenges for the Next Decade

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies?

Real Option Value and Path Dependence in Oncology Innovation

Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?

Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

The Publicly Funded Vaccines Market in the UK

The Publicly Funded Vaccines Market in Australia

Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?

The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?

Share on Mastodon